ORAL SQUAMOUS CELL CARCINOMA (OSCC)

Clinical trials for ORAL SQUAMOUS CELL CARCINOMA (OSCC) explained in plain language.

Never miss a new study

Get alerted when new ORAL SQUAMOUS CELL CARCINOMA (OSCC) trials appear

Sign up with your email to follow new studies for ORAL SQUAMOUS CELL CARCINOMA (OSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for oral cancer: major trial tests powerful drug combo

Disease control Recruiting now

This study is testing if adding an immunotherapy drug called sintilimab to standard chemotherapy, given both before and after surgery, works better than current standard treatment for people with locally advanced oral cancer. The goal is to see if this combination helps patients …

Matched conditions: ORAL SQUAMOUS CELL CARCINOMA (OSCC)

Phase: PHASE3 • Sponsor: Qunxing Li,MD • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ORAL SQUAMOUS CELL CARCINOMA (OSCC)

Get alerted when new ORAL SQUAMOUS CELL CARCINOMA (OSCC) trials appear

New hope for oral cancer: major trial tests powerful drug combo